Compare, Analyse GSK Pharma with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs ACTAVIS (US) - Comparison Results

GSK PHARMA     Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK PHARMA   ACTAVIS
EQUITY SHARE DATA
    GSK PHARMA
Mar-19
ACTAVIS
Dec-18
GSK PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs3,59513,754-   
Low Rs1,2539,226-   
Sales per share (Unadj.) Rs184.73,373.8-  
Earnings per share (Unadj.) Rs26.3-1,086.7-  
Cash flow per share (Unadj.) Rs29.2355.5-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs126.313,915.5-  
Shares outstanding (eoy) m169.40332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x13.13.4 385.4%   
Avg P/E ratio x92.2-10.6 -871.9%  
P/CF ratio (eoy) x83.132.3 257.2%  
Price / Book Value ratio x19.20.8 2,324.0%  
Dividend payout %76.10-   
Avg Mkt Cap Rs m410,6263,821,601 10.7%   
No. of employees `0005.016.9 29.3%   
Total wages/salary Rs m5,3720-   
Avg. sales/employee Rs Th6,306.766,398.8 9.5%   
Avg. wages/employee Rs Th1,083.10-   
Avg. net profit/employee Rs Th898.0-21,387.1 -4.2%   
INCOME DATA
Net Sales Rs m31,2811,122,140 2.8%  
Other income Rs m1,02321,459 4.8%   
Total revenues Rs m32,3041,143,599 2.8%   
Gross profit Rs m6,00929,406 20.4%  
Depreciation Rs m486479,690 0.1%   
Interest Rs m664,754 0.0%   
Profit before tax Rs m6,540-493,580 -1.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m287125,883 0.2%   
Tax Rs m2,373-6,255 -37.9%   
Profit after tax Rs m4,454-361,442 -1.2%  
Gross profit margin %19.22.6 733.0%  
Effective tax rate %36.31.3 2,863.2%   
Net profit margin %14.2-32.2 -44.2%  
BALANCE SHEET DATA
Current assets Rs m20,061460,243 4.4%   
Current liabilities Rs m14,543407,146 3.6%   
Net working cap to sales %17.64.7 372.8%  
Current ratio x1.41.1 122.0%  
Inventory Days Days5720 289.9%  
Debtors Days Days1466 21.2%  
Net fixed assets Rs m14,343127,020 11.3%   
Share capital Rs m1,6940-   
"Free" reserves Rs m19,7040-   
Net worth Rs m21,3984,628,303 0.5%   
Long term debt Rs m21,629,793 0.0%   
Total assets Rs m39,1137,235,091 0.5%  
Interest coverage x1,091.0-6.6 -16,474.4%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.2 515.7%   
Return on assets %11.4-4.1 -278.1%  
Return on equity %20.8-7.8 -266.5%  
Return on capital %31.9-4.8 -659.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-6,5570-   
CASH FLOW
From Operations Rs m3,994400,898 1.0%  
From Investments Rs m-1,433220,241 -0.7%  
From Financial Activity Rs m-3,584-688,062 0.5%  
Net Cashflow Rs m-1,023-66,588 1.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.08 Rs / USD

Compare GSK PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare GSK PHARMA With: TORRENT PHARMA  PANACEA BIOTECH  J.B.CHEMICALS  DR. REDDYS LAB  WOCKHARDT  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views On News

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

GSK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 16.6% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 16.6% YoY). Sales on the other hand came in at Rs 8 bn (up 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Oct 18, 2019 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE GSK PHARMA WITH

MARKET STATS